July 22, 2020

Article: How is Polpharma Biologics Innovating through the Integration of Advanced Cell Line Development Capabilities to Help Shape the Future of Healthcare?

In Pharma’s Almanac read more about integration of Bioceros’ capabilities into Polpharma Biologics. This change made Polpharma Biologics a truly integrated CDMO, offering the complete spectrum of services from discovery to commercial supply. “Polpharma Biologics is now joining the ranks of leading CDMOs with a world-class offering to help partners take their product from concept […]

Read More

July 13, 2020

Polpharma Biologics integrates Dutch based subsidiary, Bioceros, to offer the complete spectrum of services from discovery to commercial supply.

Gdansk, Poland and Utrecht, The Netherlands 13th July 2020. In 2016, Polpharma Biologics acquired Dutch based Bioceros and their proprietary cell line development platform CHOBC®, as well as their comprehensive discovery, process development and analytical capabilities. Polpharma Biologics is now taking a further step and integrating Bioceros’ Utrecht site and their advanced cell line development […]

Read More

June 24, 2020

On Demand Webinar: Looking to develop a High Quality, High Titer Manufacturing Cell Line?

We have developed our SPOT™ technology alongside our proprietary CHO cell line to increase the cell line specific productivity (Qp) which facilitate high volumetric productivity at low VCD accompanied with a simple and efficient DSP process. Watch our on demand webinar now to find out more. […]

Read More


For media inquiries, please contact:

Kamila Oliwa-Stasiak,

Communication Manager